Product Description
| Cat Number | ASC11649 |
|---|---|
| Category | Primary Antibody |
| Pack Size | 100 µg |
| Description | HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains. |
| Applications | WB, E |
| Target | GAG; P24 antibody detects a 24 kDa recombinant protein. |
| Clonality | Polyclonal |
| Gene | gag |
| Host | Rabbit |
| Isotype | IgG |
| Form | Liquid |
| Buffer | HIV-1 p24 Antibody is supplied in PBS containing 0.02% sodium azide. |
| Specie Reactivity | V |
| Reconstitution | HIV-1 p24 antibody can be stored at 4℃ for three months and -20℃, stable for up to one year. |
| Image Legend | Western blot analysis of p24 using p24 antibody at 0.5 µg/mL to detect (A) 2 ng and (B) 10 ng of recombinant HIV-1 p24. |
| References | Goto T, Nakai M, and Ikuta K. The life-cycle of human immunodeficiency virus type 1. Micron 1998; 29:123-38. Freed EO. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 1998; 251:1-15. Lindenburg CE, Stolte I, Langendam MW, et al. Long-term follow-up : no effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression. Vaccine 2002 ; 20 :2343-7. |
| Image Link | View Document |
| View Document | |
| Note | The product is for research use only |
Share Item: